RBC Capital Maintains Outperform on Medtronic, Raises Price Target to $122

RBC Capital maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $118 to $122.

Benzinga · 11/20/2019 13:39

RBC Capital maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $118 to $122.